|
MechanismCOX-2 inhibitors |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with TALLC Corp., Inc.
0 Patents (Medical) associated with TALLC Corp., Inc.
100 Deals associated with TALLC Corp., Inc.
100 Translational Medicine associated with TALLC Corp., Inc.